ArticleIranian journal of pharmaceutical research : IJPR
Protective Effects of Berberine-Loaded Black Seed (
Article in Iranian journal of pharmaceutical research : IJPR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study investigated atherosclerosis (AS), a pivotal contributor to the onset of coronary artery disease and other cardiovascular ailments.. Objectives: The presents study examined a novel therapeutic strategy combining black seed oil [ Methods: After preparing the NS nanoemulsion, gas chromatography-mass spectrometry (GC-MS) was used for analysis. A BBR-loaded black seed oil-based nanoemulsion (BBS) was developed and evaluated for its thermodynamic stability, viscosity, particle size, and dynamic light scattering (DLS) properties. Forty-eight male C57BL/6J mice (8 weeks old, 18 - 20 g) were divided into six groups and fed a modified AIN-76 diet with 25% dietary fat for 16 weeks to induce AS. Treatment began after 8 weeks through oral gavage for the remaining 8 weeks. Levels of low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride (TG), and total cholesterol were measured, along with the atherogenic coefficient and cardiac risk ratio. We also quantified malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GPX), and catalase (CAT) activities, and assessed pathological changes in cardiac and aortic tissues using hematoxylin and eosin (H&E) staining. Results: The GC-MS analysis confirmed that NS oil met quality benchmarks, displaying stability with a zeta potential of -18.4 mV. The study showed a Polydispersity Index (PDI) of 0.3019 and a Z-average of 250.4 nm. The BBS improved lipid profiles in mice, increasing HDL and decreasing LDL, TG, and total cholesterol, thereby reducing cardiac risk. The formulation exhibited strong antioxidant effects, with reduced MDA levels and enhanced SOD, GPX, and CAT activities. Pathological observations supported these biochemical results. Conclusions: Our findings suggest that BBS offers valuable insights into the mechanisms underlying atherosclerotic disease. This understanding could pave the way for novel approaches to cardiovascular health and the development of effective preventive strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.